The DOI matches its Crossref record; 112 of the 112 references it cites were found in a registry or an index.
HIV-1 and interferons: who's interfering with whom?
Open accessAbstract
The ability of interferons (IFNs) to inhibit HIV-1 replication in cell culture models has long been recognized, and the therapeutic administration of IFNα to HIV-1-infected patients who are not receiving antiretroviral therapy produces a clear but transient decrease in plasma viral load. Conversely, studies of chronic HIV-1 infection in humans and SIV-infected animal models of AIDS show positive correlations between elevated plasma levels of IFNs, increased expression of IFN-stimulated genes (ISGs), biomarkers of inflammation and disease progression. In this Review, we discuss the evidence that IFNs can control HIV-1 replication in vivo and debate the controversial role of IFNs in promoting the pathological sequelae of chronic HIV-1 infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pattern Recognition Receptors and Inflammation
Takeuchi, O., & Akira, S. (2010) · Cell · doi:10.1016/j.cell.2010.01.022 · Cited by 8,895
Type I interferons in infectious disease
McNab, F., Mayer-Barber, K., Sher, A., Wack, A., & O'Garra, A. (2015) · Nature Reviews Immunology · doi:10.1038/nri3787 · Cited by 2,780
A diverse range of gene products are effectors of the type I interferon antiviral response
Schoggins, J. W., Wilson, S. J., Panis, M., Murphy, M. Y., Jones, C. T., Bieniasz, P., & Rice, C. M. (2011) · Nature · doi:10.1038/nature09907 · Cited by 2,433
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein
Sheehy, A. M., Gaddis, N. C., Choi, J. D., & Malim, M. H. (2002) · Nature · doi:10.1038/nature00939 · Cited by 2,327
Self-citationTetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu
Neil, S. J. D., Zang, T., & Bieniasz, P. D. (2008) · Nature · doi:10.1038/nature06553 · Cited by 1,902
The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys
Stremlau, M., Owens, C. M., Perron, M. J., Kiessling, M., Autissier, P., & Sodroski, J. (2004) · Nature · doi:10.1038/nature02343 · Cited by 1,816
IFI16 is an innate immune sensor for intracellular DNA
Unterholzner, L., Keating, S. E., Baran, M., Horan, K. A., Jensen, S. B., Sharma, S., Sirois, C. M., Jin, T., Latz, E., Xiao, T. S., et al. (2010) · Nature Immunology · doi:10.1038/ni.1932 · Cited by 1,643
SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx
Laguette, N., Sobhian, B., Casartelli, N., Ringeard, M., Chable-Bessia, C., Ségéral, E., Yatim, A., Emiliani, S., Schwartz, O., & Benkirane, M. (2011) · Nature · doi:10.1038/nature10117 · Cited by 1,511
Origins of HIV and the AIDS Pandemic
Sharp, P. M., & Hahn, B. H. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006841 · Cited by 1,496
Intracellular Toll-like Receptors
Blasius, A. L., & Beutler, B. (2010) · Immunity · doi:10.1016/j.immuni.2010.03.012 · Cited by 1,325
Torriani, F. J., Rodriguez-Torres, M., Rockstroh, J. K., Lissen, E., Gonzalez-García, J., Lazzarin, A., Carosi, G., Sasadeusz, J., Katlama, C., Montaner, J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040842 · Cited by 1,233
Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein
Hrecka, K., Hao, C., Gierszewska, M., Swanson, S. K., Kesik-Brodacka, M., Srivastava, S., Florens, L., Washburn, M. P., & Skowronski, J. (2011) · Nature · doi:10.1038/nature10195 · Cited by 1,200
Induction of APOBEC3G Ubiquitination and Degradation by an HIV-1 Vif-Cul5-SCF Complex
Yu, X., Yu, Y., Liu, B., Luo, K., Kong, W., Mao, P., & Yu, X.-F. (2003) · Science · doi:10.1126/science.1089591 · Cited by 1,200
Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection
Doitsh, G., Galloway, N. L. K., Geng, X., Yang, Z., Monroe, K. M., Zepeda, O., Hunt, P. W., Hatano, H., Sowinski, S., Muñoz-Arias, I., et al. (2014) · Nature · doi:10.1038/nature12940 · Cited by 1,179
Van Damme, N., Goff, D., Katsura, C., Jorgenson, R. L., Mitchell, R., Johnson, M. C., Stephens, E. B., & Guatelli, J. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.03.001 · Cited by 1,050
Cyclic GMP-AMP Synthase Is an Innate Immune Sensor of HIV and Other Retroviruses
Gao, D., Wu, J., Wu, Y.-T., Du, F., Aroh, C., Yan, N., Sun, L., & Chen, Z. J. (2013) · Science · doi:10.1126/science.1240933 · Cited by 992
Le Bon, A., Schiavoni, G., D'Agostino, G., Gresser, I., Belardelli, F., & Tough, D. F. (2001) · Immunity · doi:10.1016/s1074-7613(01)00126-1 · Cited by 974
Kolumam, G. A., Thomas, S., Thompson, L. J., Sprent, J., & Murali-Krishna, K. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050821 · Cited by 965
Prokunina-Olsson, L., Muchmore, B., Tang, W., Pfeiffer, R. M., Park, H., Dickensheets, H., Hergott, D., Porter-Gill, P., Mumy, A., Kohaar, I., et al. (2013) · Nature Genetics · doi:10.1038/ng.2521 · Cited by 928
Functional classification of interferon-stimulated genes identified using microarrays
de Veer, M. J., Holko, M., Frevel, M., Walker, E., Der, S., Paranjape, J. M., Silverman, R. H., & Williams, B. R. G. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.69.6.912 · Cited by 900
Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity
Schoggins, J. W., MacDuff, D. A., Imanaka, N., Gainey, M. D., Shrestha, B., Eitson, J. L., Mar, K. B., Richardson, R. B., Ratushny, A. V., Litvak, V., et al. (2014) · Nature · doi:10.1038/nature12862 · Cited by 896
Lahouassa, H., Daddacha, W., Hofmann, H., Ayinde, D., Logue, E. C., Dragin, L., Bloch, N., Maudet, C., Bertrand, M., Gramberg, T., et al. (2012) · Nature Immunology · doi:10.1038/ni.2236 · Cited by 852
Goubau, D., Deddouche, S., & Reis e Sousa, C. (2013) · Immunity · doi:10.1016/j.immuni.2013.05.007 · Cited by 843
HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase
Goldstone, D. C., Ennis-Adeniran, V., Hedden, J. J., Groom, H. C. T., Rice, G. I., Christodoulou, E., Walker, P. A., Kelly, G., Haire, L. F., Yap, M. W., et al. (2011) · Nature · doi:10.1038/nature10623 · Cited by 831
Stacey, A. R., Norris, P. J., Qin, L., Haygreen, E. A., Taylor, E., Heitman, J., Lebedeva, M., DeCamp, A., Li, D., Grove, D., et al. (2009) · Journal of Virology · doi:10.1128/jvi.01844-08 · Cited by 747
The early spread and epidemic ignition of HIV-1 in human populations
Faria, N. R., Rambaut, A., Suchard, M. A., Baele, G., Bedford, T., Ward, M. J., Tatem, A. J., Sousa, J. D., Arinaminpathy, N., Pépin, J., et al. (2014) · Science · doi:10.1126/science.1256739 · Cited by 736
Beignon, A.-S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26032 · Cited by 673
TRIM5 is an innate immune sensor for the retrovirus capsid lattice
Pertel, T., Hausmann, S., Morger, D., Züger, S., Guerra, J., Lascano, J., Reinhard, C., Santoni, F. A., Uchil, P. D., Chatel, L., et al. (2011) · Nature · doi:10.1038/nature09976 · Cited by 645
Interferon signaling and treatment outcome in chronic hepatitis C
Sarasin-Filipowicz, M., Oakeley, E. J., Duong, F. H. T., Christen, V., Terracciano, L., Filipowicz, W., & Heim, M. H. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707882105 · Cited by 642
Emerging Concepts in the Immunopathogenesis of AIDS
Douek, D. C., Roederer, M., & Koup, R. A. (2009) · Annual Review of Medicine · doi:10.1146/annurev.med.60.041807.123549 · Cited by 612
Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection
Goujon, C., Moncorgé, O., Bauby, H., Doyle, T., Ward, C. C., Schaller, T., Hué, S., Barclay, W. S., Schulz, R., & Malim, M. H. (2013) · Nature · doi:10.1038/nature12542 · Cited by 583
Self-citationInterferon signalling network in innate defence
Takaoka, A., & Yanai, H. (2006) · Cellular Microbiology · doi:10.1111/j.1462-5822.2006.00716.x · Cited by 581
Interferon-inducible effector mechanisms in cell-autonomous immunity
MacMicking, J. D. (2012) · Nature Reviews Immunology · doi:10.1038/nri3210 · Cited by 579
Yan, N., & Chen, Z. J. (2012) · Nature Immunology · doi:10.1038/ni.2229 · Cited by 532
Yan, N., Regalado-Magdos, A. D., Stiggelbout, B., Lee-Kirsch, M. A., & Lieberman, J. (2010) · Nature Immunology · doi:10.1038/ni.1941 · Cited by 529
IFI16 DNA Sensor Is Required for Death of Lymphoid CD4 T Cells Abortively Infected with HIV
Monroe, K. M., Yang, Z., Johnson, J. R., Geng, X., Doitsh, G., Krogan, N. J., & Greene, W. C. (2014) · Science · doi:10.1126/science.1243640 · Cited by 511
MX2 is an interferon-induced inhibitor of HIV-1 infection
Kane, M., Yadav, S. S., Bitzegeio, J., Kutluay, S. B., Zang, T., Wilson, S. J., Schoggins, J. W., Rice, C. M., Yamashita, M., Hatziioannou, T., et al. (2013) · Nature · doi:10.1038/nature12653 · Cited by 509
Direct Effects of Type I Interferons on Cells of the Immune System
Hervas-Stubbs, S., Perez-Gracia, J. L., Rouzaut, A., Sanmamed, M. F., Le Bon, A., & Melero, I. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1114 · Cited by 503
Positional cloning of the mouse retrovirus restriction gene Fvl
Best, S., Tissier, P. L., Towers, G., & Stoye, J. P. (1996) · Nature · doi:10.1038/382826a0 · Cited by 493
HIV Restriction Factors and Mechanisms of Evasion
Malim, M. H., & Bieniasz, P. D. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006940 · Cited by 487
Self-citationJacquelin, B., Mayau, V., Targat, B., Liovat, A.-S., Kunkel, D., Petitjean, G., Dillies, M.-A., Roques, P., Butor, C., Silvestri, G., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci40093 · Cited by 481
Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression
Sandler, N. G., Bosinger, S. E., Estes, J. D., Zhu, R. T. R., Tharp, G. K., Boritz, E., Levin, D., Wijeyesinghe, S., Makamdop, K. N., del Prete, G. Q., et al. (2014) · Nature · doi:10.1038/nature13554 · Cited by 461
HIV-1 evades innate immune recognition through specific cofactor recruitment
Rasaiyaah, J., Tan, C. P., Fletcher, A. J., Price, A. J., Blondeau, C., Hilditch, L., Jacques, D. A., Selwood, D. L., James, L. C., Noursadeghi, M., et al. (2013) · Nature · doi:10.1038/nature12769 · Cited by 458
Abortive HIV Infection Mediates CD4 T Cell Depletion and Inflammation in Human Lymphoid Tissue
Doitsh, G., Cavrois, M., Lassen, K. G., Zepeda, O., Yang, Z., Santiago, M. L., Hebbeler, A. M., & Greene, W. C. (2010) · Cell · doi:10.1016/j.cell.2010.11.001 · Cited by 452
Systematic identification of type I and type II interferon-induced antiviral factors
Liu, S.-Y., Sanchez, D. J., Aliyari, R., Lu, S., & Cheng, G. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1114981109 · Cited by 445
Phenotypic properties of transmitted founder HIV-1
Parrish, N. F., Gao, F., Li, H., Giorgi, E. E., Barbian, H. J., Parrish, E. H., Zajic, L., Iyer, S. S., Decker, J. M., Kumar, A., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1304288110 · Cited by 422
The IFITM Proteins Inhibit HIV-1 Infection
Lu, J., Pan, Q., Rong, L., Liu, S.-L., & Liang, C. (2011) · Journal of Virology · doi:10.1128/jvi.01531-10 · Cited by 417
Bosinger, S. E., Li, Q., Gordon, S. N., Klatt, N. R., Duan, L., Xu, L., Francella, N., Sidahmed, A., Smith, A. J., Cramer, E. M., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci40115 · Cited by 409
Lahaye, X., Satoh, T., Gentili, M., Cerboni, S., Conrad, C., Hurbain, I., El Marjou, A., Lacabaratz, C., Lelièvre, J.-D., & Manel, N. (2013) · Immunity · doi:10.1016/j.immuni.2013.11.002 · Cited by 390
Codon-usage-based inhibition of HIV protein synthesis by human schlafen 11
Li, M., Kao, E., Gao, X., Sandig, H., Limmer, K., Pavon-Eternod, M., Jones, T. E., Landry, S., Pan, T., Weitzman, M. D., et al. (2012) · Nature · doi:10.1038/nature11433 · Cited by 375
IFI16 senses DNA forms of the lentiviral replication cycle and controls HIV-1 replication
Jakobsen, M. R., Bak, R. O., Andersen, A., Berg, R. K., Jensen, S. B., Jin, T., Laustsen, A., Hansen, K., Østergaard, L., Fitzgerald, K. A., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1311669110 · Cited by 344
Type I IFN Contributes to NK Cell Homeostasis, Activation, and Antitumor Function
Swann, J. B., Hayakawa, Y., Zerafa, N., Sheehan, K. C. F., Scott, B., Schreiber, R. D., Hertzog, P., & Smyth, M. J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.12.7540 · Cited by 339
The Interferon-Inducible MxB Protein Inhibits HIV-1 Infection
Liu, Z., Pan, Q., Ding, S., Qian, J., Xu, F., Zhou, J., Cen, S., Guo, F., & Liang, C. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.08.015 · Cited by 334
Immune Evasion and Counteraction of Restriction Factors by HIV-1 and Other Primate Lentiviruses
Kirchhoff, F. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.06.004 · Cited by 315
Interferon-stimulated genes: roles in viral pathogenesis
Schoggins, J. W. (2014) · Current Opinion in Virology · doi:10.1016/j.coviro.2014.03.006 · Cited by 314
RECOMBINANT HUMAN INTERFERON ALFA-A SUPPRESSES HTLV-III REPLICATION IN VITRO
Ho, D., Rota, T., Kaplan, J., Hartshorn, K., Andrews, C., Schooley, R., & Hirsch, M. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92144-0 · Cited by 305
Macrophage Tropism of HIV-1 Depends on Efficient Cellular dNTP Utilization by Reverse Transcriptase
Diamond, T. L., Roshal, M., Jamburuthugoda, V. K., Reynolds, H. M., Merriam, A. R., Lee, K. Y., Balakrishnan, M., Bambara, R. A., Planelles, V., Dewhurst, S., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408573200 · Cited by 290
Neil, S. J. D., Sandrin, V., Sundquist, W. I., & Bieniasz, P. D. (2007) · Cell Host & Microbe · doi:10.1016/j.chom.2007.08.001 · Cited by 275
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction
Ryoo, J., Choi, J., Oh, C., Kim, S., Seo, M., Kim, S.-Y., Seo, D., Kim, J., White, T. E., Brandariz-Nuñez, A., et al. (2014) · Nature Medicine · doi:10.1038/nm.3626 · Cited by 274
Kornbluth, R. S., Oh, P. S., Munis, J. R., Cleveland, P. H., & Richman, D. D. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.3.1137 · Cited by 270
Innate Sensing of HIV-1 Assembly by Tetherin Induces NFκB-Dependent Proinflammatory Responses
Galão, R. P., Le Tortorec, A., Pickering, S., Kueck, T., & Neil, S. J. D. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.10.007 · Cited by 267
IFITM Proteins Incorporated into HIV-1 Virions Impair Viral Fusion and Spread
Compton, A. A., Bruel, T., Porrot, F., Mallet, A., Sachse, M., Euvrard, M., Liang, C., Casartelli, N., & Schwartz, O. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.11.001 · Cited by 231
Lane, H. C., Davey, V., Kovacs, J. A., Feinberg, J., Metcalf, J. A., Herpin, B., Walker, R., Deyton, L., Davey, R. T., Falloon, J., et al. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-11-805 · Cited by 228
Origin of the HIV-1 group O epidemic in western lowland gorillas
D’arc, M., Ayouba, A., Esteban, A., Learn, G. H., Boué, V., Liegeois, F., Etienne, L., Tagg, N., Leendertz, F. H., Boesch, C., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1502022112 · Cited by 215
Herbeuval, J.-P. (2005) · Blood · doi:10.1182/blood-2005-03-1243 · Cited by 211
Immunologic strategies for HIV-1 remission and eradication
Barouch, D. H., & Deeks, S. G. (2014) · Science · doi:10.1126/science.1255512 · Cited by 211
Structural basis for hijacking CBF-β and CUL5 E3 ligase complex by HIV-1 Vif
Guo, Y., Dong, L., Qiu, X., Wang, Y., Zhang, B., Liu, H., Yu, Y., Zang, Y., Yang, M., & Huang, Z. (2014) · Nature · doi:10.1038/nature12884 · Cited by 202
Relative resistance of HIV-1 founder viruses to control by interferon-alpha
Fenton-May, A. E., Dibben, O., Emmerich, T., Ding, H., Pfafferott, K., Aasa-Chapman, M. M., Pellegrino, P., Williams, I., Cohen, M. S., Gao, F., et al. (2013) · Retrovirology · doi:10.1186/1742-4690-10-146 · Cited by 197
Innate Sensing of HIV-Infected Cells
Lepelley, A., Louis, S., Sourisseau, M., Law, H. K. W., Pothlichet, J., Schilte, C., Chaperot, L., Plumas, J., Randall, R. E., Si-Tahar, M., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1001284 · Cited by 195
Hyrcza, M. D., Kovacs, C., Loutfy, M., Halpenny, R., Heisler, L., Yang, S., Wilkins, O., Ostrowski, M., & Der, S. D. (2007) · Journal of Virology · doi:10.1128/jvi.01552-06 · Cited by 190
Azzoni, L., Foulkes, A. S., Papasavvas, E., Mexas, A. M., Lynn, K. M., Mounzer, K., Tebas, P., Jacobson, J. M., Frank, I., Busch, M. P., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis663 · Cited by 189
Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics
Albin, J. S., & Harris, R. S. (2010) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399409001343 · Cited by 186
Wood, N., Bhattacharya, T., Keele, B. F., Giorgi, E., Liu, M., Gaschen, B., Daniels, M., Ferrari, G., Haynes, B. F., McMichael, A., et al. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000414 · Cited by 176
Paolini, R., Bernardini, G., Molfetta, R., & Santoni, A. (2015) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.11.003 · Cited by 171
Rotger, M., Dang, K. K., Fellay, J., Heinzen, E. L., Feng, S., Descombes, P., Shianna, K. V., Ge, D., Günthard, H. F., Goldstein, D. B., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000781 · Cited by 168
Hardy, G. A. D., Sieg, S., Rodriguez, B., Anthony, D., Asaad, R., Jiang, W., Mudd, J., Schacker, T., Funderburg, N. T., Pilch-Cooper, H. A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056527 · Cited by 167
Srivastava, S., Koch, M. A., Pepper, M., & Campbell, D. J. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20131556 · Cited by 162
Alpha interferon inhibits early stages of the human immunodeficiency virus type 1 replication cycle
Shirazi, Y., & Pitha, P. M. (1992) · Journal of Virology · doi:10.1128/jvi.66.3.1321-1328.1992 · Cited by 161
Sedaghat, A. R., German, J., Teslovich, T. M., Cofrancesco, J., Jie, C. C., Talbot, C. C., & Siliciano, R. F. (2008) · Journal of Virology · doi:10.1128/jvi.02228-07 · Cited by 161
MxB binds to the HIV-1 core and prevents the uncoating process of HIV-1
Fricke, T., White, T. E., Schulte, B., de Souza Aranha Vieira, D. A., Dharan, A., Campbell, E. M., Brandariz-Nuñez, A., & Diaz-Griffero, F. (2014) · Retrovirology · doi:10.1186/preaccept-6453674081373986 · Cited by 161
Matreyek, K. A., & Engelman, A. (2013) · Viruses · doi:10.3390/v5102483 · Cited by 160
IFITM proteins are incorporated onto HIV-1 virion particles and negatively imprint their infectivity
Tartour, K., Appourchaux, R., Burlaud‐Gaillard, J., Nguyen, X.-N., Durand, S., Turpin, J., Beaumont, É., Roch, E., Berger, G., Mahieux, R., et al. (2014) · Retrovirology · doi:10.1186/s12977-014-0103-y · Cited by 157
Meylan, P. R., Guatelli, J., Munis, J. R., et al. (1993) · Virology · doi:10.1006/viro.1993.1110 · Cited by 148
Goujon, C., & Malim, M. H. (2010) · Journal of Virology · doi:10.1128/jvi.00854-10 · Cited by 147
Self-citationHuman Immunodeficiency Virus, Restriction Factors, and Interferon
Neil, S. J. D., & Bieniasz, P. D. (2009) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2009.0077 · Cited by 146
Melén, K., Keskinen, P., Ronni, T., Sareneva, T., Lounatmaa, K., & Julkunen, I. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.38.23478 · Cited by 138
Structural Insight into HIV-1 Restriction by MxB
Fribourgh, J. L., Nguyen, H. C., Matreyek, K. A., Alvarez, F. J. D., Summers, B. J., Dewdney, T. G., Aiken, C., Zhang, P., Engelman, A., & Xiong, Y. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.09.021 · Cited by 126
Asmuth, D. M., Murphy, R. L., Rosenkranz, S. L., Lertora, J. J. L., Kottilil, S., Cramer, Y. S., Chan, E. S., Schooley, R. T., Rinaldo, C. R., Thielman, N. M., et al. (2010) · The Journal of Infectious Diseases · doi:10.1086/652420 · Cited by 122
Role of retroviral restriction factors in the interferon-α–mediated suppression of HIV-1 in vivo
Pillai, S. K., Abdel‐Mohsen, M., Guatelli, J., Skasko, M., Monto, A., Fujimoto, K., Yukl, S. A., Greene, W. C., Kovari, H., Rauch, A., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1111573109 · Cited by 121
Li, G., Cheng, M., Nunoya, J.-I., Cheng, L., Guo, H., Yu, H., Liu, Y.-J., Su, L., & Zhang, L. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004291 · Cited by 115
The Antiviral Activities of Tetherin
Neil, S. J. D. (2013) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-37765-5_3 · Cited by 113
Interferon, a growing cytokine family: 50 years of interferon research
Chelbi‐Alix, M. K., & Wietzerbin, J. (2007) · Biochimie · doi:10.1016/j.biochi.2007.05.001 · Cited by 112
Marshall, H. D., Urban, S. L., & Welsh, R. M. (2011) · Journal of Virology · doi:10.1128/jvi.02516-10 · Cited by 99
Goujon, C., Moncorgé, O., Bauby, H., Doyle, T., Barclay, W., & Malim, M. H. (2014) · Journal of Virology · doi:10.1128/jvi.01269-14 · Cited by 98
Self-citationFraietta, J. A., Mueller, Y. M., Yang, G., Boesteanu, A. C., Gracias, D. T., Do, D. H., Hope, J. L., Kathuria, N., McGettigan, S. E., Lewis, M. G., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003658 · Cited by 97
Zanoni, I., Spreafico, R., Bodio, C., Gioia, M. D., Cigni, C., Broggi, A., Gorletta, T., Caccia, M., Chirico, G. G., Sironi, L., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.08.021 · Cited by 96
Kim, E., Lorenzo-Redondo, R., Little, S. J., Chung, Y., Phalora, P. K., Berry, I. M., Archer, J. P., Penugonda, S., Fischer, W., Richman, D. D., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004281 · Cited by 94
Self-citationArmitage, A. E., Katzourakis, A., de Oliveira, T., Welch, J. J., Belshaw, R. D., Bishop, K. N., Kramer, B., McMichael, A. J., Rambaut, A., & Iversen, A. K. N. (2008) · Journal of Virology · doi:10.1128/jvi.00584-08 · Cited by 89
HIV-1 infection of macrophages is dependent on evasion of innate immune cellular activation
Tsang, J., Chain, B., Miller, R. F., Webb, B. L. J., Barclay, W., Towers, G. J., Katz, D. R., & Noursadeghi, M. (2009) · AIDS · doi:10.1097/qad.0b013e328331a4ce · Cited by 86
Hiding in Plain Sight: How HIV Evades Innate Immune Responses
Manel, N., & Littman, D. R. (2011) · Cell · doi:10.1016/j.cell.2011.09.010 · Cited by 85
Kader, M., Smith, A. P., Guiducci, C., Wonderlich, E. R., Normolle, D. P., Watkins, S. C., Barrat, F. J., & Barratt‐Boyes, S. M. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003530 · Cited by 69
Jacquelin, B., Petitjean, G., Kunkel, D., Liovat, A.-S., Jochems, S. P., Rogers, K. A., Ploquin, M. J.-Y., Madec, Y., Barré‐Sinoussi, F., Dereuddre‐Bosquet, N., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004241 · Cited by 67
Interferon type I responses in primary and secondary infections
Alsharifi, M., Müllbacher, A., & Regner, M. (2008) · Immunology and Cell Biology · doi:10.1038/sj.icb.7100159 · Cited by 62
Retroviral Retention Activates a Syk-Dependent HemITAM in Human Tetherin
Galão, R. P., Pickering, S., Curnock, R., & Neil, S. J. D. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.08.005 · Cited by 62
Bruel, T., Dupuy, S., Démoulins, T., Rogez‐Kreuz, C., Dutrieux, J., Corneau, A., Cosma, A., Cheynier, R., Dereuddre‐Bosquet, N., Grand, R. L., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1003915 · Cited by 61
Sun, H., Buzón, M. J., Shaw, A., Berg, R., Yu, X. G., Ferrando‐Martínez, S., Leal, M., Ruíz-Mateos, E., & Lichterfeld, M. D. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit628 · Cited by 59
Cheney, K. M., & McKnight, Á. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013521 · Cited by 57
Vanderford, T. H., Slichter, C. K., Rogers, K. A., Lawson, B., Obaede, R., Else, J. G., Villinger, F. J., Bosinger, S. E., & Silvestri, G. (2012) · Blood · doi:10.1182/blood-2012-02-411496 · Cited by 54
Bahl, K., Hübner, A., Davis, R. J., & Welsh, R. M. (2010) · Journal of Virology · doi:10.1128/jvi.02571-09 · Cited by 43
Neumann, A., Polis, M. A., Rozenberg, L., Jackson, J., Reitano, K. N., McLaughlin, M. E., Koratich, C., Dewar, R., Masur, H., Haagmans, B. L., et al. (2007) · AIDS · doi:10.1097/qad.0b013e32825eaba7 · Cited by 35
Schaller, T., Goujon, C., & Malim, M. H. (2012) · Science · doi:10.1126/science.1221057 · Cited by 22
Self-citationHubbard, J. J., Greenwell‐Wild, T., Barrett, L. F., Yang, J., Lempicki, R. A., Wahl, S. M., Asmuth, D. M., Murphy, R. L., Pollard, R. B., & Kottilil, S. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis211 · Cited by 22
Cited by
Host-directed therapies for bacterial and viral infections
Kaufmann, S. H. E., Dorhoi, A., Hotchkiss, R. S., & Bartenschlager, R. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.162 · Cited by 831
HIV-1 capsid: the multifaceted key player in HIV-1 infection
Campbell, E. M., & Hope, T. J. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3503 · Cited by 430
Pathogenesis of HIV-1 and Mycobacterium tuberculosis co-infection
Bell, L. C. K., & Noursadeghi, M. (2018) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.128 · Cited by 389
Identification of Interferon-Stimulated Genes with Antiretroviral Activity
Kane, M., Zang, T. M., Rihn, S. J., Zhang, F., Kueck, T., Alim, M., Schoggins, J., Rice, C. M., Wilson, S. J., & Bieniasz, P. D. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.08.005 · Cited by 261
Guanylate Binding Protein (GBP) 5 Is an Interferon-Inducible Inhibitor of HIV-1 Infectivity
Krapp, C., Hotter, D., Gawanbacht, A., McLaren, P. J., Kluge, S. F., Stürzel, C. M., Mack, K., Reith, E., Engelhart, S., Ciuffi, A., et al. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.02.019 · Cited by 256
Metadata
- Authors
- Doyle, T., Goujon, C., & Malim, M. H.
- Venue
- Nature Reviews Microbiology
- Published
- 2015-04-27
- Volume
- 13
- Issue
- 7
- Pages
- 403-413
- ISSN
- 1740-1526 (ISSN-L)
- 1740-1534
- OpenAlex
- W1966060871
- Cited by
- 285
- References
- 112
- FWCI
- 3.39
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.